MedSci Healthcare Holdings Limited (HKG:2415)
Hong Kong · Delayed Price · Currency is HKD 0.7600
-0.0050 (-0.65%)
Sep 10, 2026, 4:08 PM HKT
HKG:2415 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 416 | 676 | 472 | 2,581 | - | - | |
Market Cap Growth | -55.51% | 43.33% | -81.73% | - | - | - |
Enterprise Value | -969 | -658 | -761 | 1,348 | - | - |
Last Close Price | 0.76 | 1.25 | 0.87 | 4.74 | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 26.28 | 33.86 | 17.75 | 42.57 | - | - |
Forward PE | - | 18.72 | 20.56 | 24.52 | - | - |
PS Ratio | 1.37 | 2.25 | 1.70 | 6.71 | - | - |
PB Ratio | 0.31 | 0.51 | 0.38 | 2.09 | - | - |
P/TBV Ratio | 0.31 | 0.52 | 0.38 | 2.10 | - | - |
P/FCF Ratio | - | 305.04 | 8.11 | 61.89 | - | - |
P/OCF Ratio | - | 300.37 | 8.08 | 61.60 | - | - |
PEG Ratio | - | 1.44 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | - | - | - | 3.50 | - | - |
EV/EBITDA Ratio | - | - | - | 70.30 | - | - |
EV/EBIT Ratio | - | - | - | 75.23 | - | - |
EV/FCF Ratio | - | - | - | 32.31 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.00 | -5.13 | -9.03 |
Debt / EBITDA Ratio | 0.33 | 0.33 | - | 0.19 | 83.24 | 13.61 |
Debt / FCF Ratio | - | 3.14 | 0.04 | 0.12 | - | 16.65 |
Net Debt / Equity Ratio | -1.03 | -1.00 | -1.03 | -1.01 | -0.91 | -0.14 |
Net Debt / EBITDA Ratio | -73.16 | -79.84 | 85.16 | -65.13 | 80.26 | 0.26 |
Net Debt / FCF Ratio | - | -594.17 | -22.09 | -29.94 | -8.93 | 0.26 |
Asset Turnover | 0.19 | 0.20 | 0.20 | 0.34 | 0.48 | 0.56 |
Quick Ratio | 6.68 | 6.47 | 7.36 | 7.24 | 4.31 | 3.94 |
Current Ratio | 6.70 | 6.73 | 7.37 | 7.26 | 4.36 | 3.97 |
Return on Equity (ROE) | 1.31% | 1.53% | 2.18% | 11.25% | - | -233.26% |
Return on Assets (ROA) | 0.70% | 0.63% | -0.71% | 1.00% | 0.04% | 4.26% |
Return on Invested Capital (ROIC) | - | - | - | 5.20% | 0.08% | 15.57% |
Return on Capital Employed (ROCE) | 1.30% | 1.20% | -1.30% | 1.50% | 0.10% | 6.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.25% | 2.95% | 5.63% | 2.35% | - | - |
FCF Yield | - | 0.33% | 12.32% | 1.62% | - | - |
Dividend Yield | 1.45% | 0.88% | - | - | - | - |
Payout Ratio | - | 32.09% | - | - | - | - |
Buyback Yield / Dilution | -1.88% | -1.29% | -4.23% | -9.74% | -5419.00% | 10.35% |
Total Shareholder Return | -0.44% | -0.40% | -4.23% | -9.74% | -5419.00% | 10.35% |